These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 24029425)

  • 1. Diabetic nephropathy: is ESRD its only heritable phenotype?
    Pezzolesi MG; Krolewski AS
    J Am Soc Nephrol; 2013 Oct; 24(10):1505-7. PubMed ID: 24029425
    [No Abstract]   [Full Text] [Related]  

  • 2. Chromosome 2q31.1 associates with ESRD in women with type 1 diabetes.
    Sandholm N; McKnight AJ; Salem RM; Brennan EP; Forsblom C; Harjutsalo V; Mäkinen VP; McKay GJ; Sadlier DM; Williams WW; Martin F; Panduru NM; Tarnow L; Tuomilehto J; Tryggvason K; Zerbini G; Comeau ME; Langefeld CD; ; Godson C; Hirschhorn JN; Maxwell AP; Florez JC; Groop PH;
    J Am Soc Nephrol; 2013 Oct; 24(10):1537-43. PubMed ID: 24029427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PPAR gamma 2 Pro12Ala variant predicts ESRD and mortality in patients with type 1 diabetes and diabetic nephropathy.
    Jorsal A; Tarnow L; Lajer M; Ek J; Hansen T; Pedersen O; Parving HH
    Mol Genet Metab; 2008 Jul; 94(3):347-51. PubMed ID: 18467141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of the relationship between ACE I/D gene polymorphism and end-stage renal disease in patients with diabetic nephropathy.
    Yu ZY; Chen LS; Zhang LC; Zhou TB
    Nephrology (Carlton); 2012 Jul; 17(5):480-7. PubMed ID: 22385293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD2AP is associated with end-stage renal disease in patients with type 1 diabetes.
    Hyvönen ME; Ihalmo P; Sandholm N; Stavarachi M; Forsblom C; McKnight AJ; Lajer M; Maestroni A; Lewis G; Tarnow L; Maestroni S; Zerbini G; Parving HH; Maxwell AP; Groop PH; Lehtonen S
    Acta Diabetol; 2013 Dec; 50(6):887-97. PubMed ID: 23681557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelic variations in the CYBA gene of NADPH oxidase and risk of kidney complications in patients with type 1 diabetes.
    Patente TA; Mohammedi K; Bellili-Muñoz N; Driss F; Sanchez M; Fumeron F; Roussel R; Hadjadj S; Corrêa-Giannella ML; Marre M; Velho G
    Free Radic Biol Med; 2015 Sep; 86():16-24. PubMed ID: 25862415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of +35A/C (intron3/exon3) polymorphism in SOD1-gene with diabetic nephropathy in type 1 diabetes.
    Panduru NM; Cimponeriu D; Cruce M; Ion DA; Moţa E; Moţa M; Serafinceanu C; Chivu LI; Panduru M; Chivu RD; Covic AC
    Rom J Morphol Embryol; 2010; 51(1):37-41. PubMed ID: 20191117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum C-peptide concentrations poorly phenotype type 2 diabetic end-stage renal disease patients.
    Covic AM; Schelling JR; Constantiner M; Iyengar SK; Sedor JR
    Kidney Int; 2000 Oct; 58(4):1742-50. PubMed ID: 11012908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diabetic patient with renal failure.
    Ritz E; Schömig M
    Nefrologia; 2000; 20 Suppl 3():16-24. PubMed ID: 10835873
    [No Abstract]   [Full Text] [Related]  

  • 10. Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes.
    Pezzolesi MG; Poznik GD; Mychaleckyj JC; Paterson AD; Barati MT; Klein JB; Ng DP; Placha G; Canani LH; Bochenski J; Waggott D; Merchant ML; Krolewski B; Mirea L; Wanic K; Katavetin P; Kure M; Wolkow P; Dunn JS; Smiles A; Walker WH; Boright AP; Bull SB; ; Doria A; Rogus JJ; Rich SS; Warram JH; Krolewski AS
    Diabetes; 2009 Jun; 58(6):1403-10. PubMed ID: 19252134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism of catalase gene promoter in Romanian patients with diabetic kidney disease and type 1 diabetes.
    Panduru NM; Moţa E; Moţa M; Cimponeriu D; Serafinceanu C; Cheţa DM
    Rom J Intern Med; 2010; 48(1):81-8. PubMed ID: 21180245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylenetetrahydrofolate reductase gene polymorphism and susceptibility to diabetic nephropathy in type 1 diabetes.
    Makita Y; Moczulski DK; Bochenski J; Smiles AM; Warram JH; Krolewski AS
    Am J Kidney Dis; 2003 Jun; 41(6):1189-94. PubMed ID: 12776270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the association of BMP gene variants with nephropathy in Type 1 diabetes mellitus.
    McKnight AJ; Pettigrew KA; Patterson CC; Kilner J; Sadlier DM; Maxwell AP;
    Diabet Med; 2010 Jun; 27(6):624-30. PubMed ID: 20546278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variation in the Renin-Angiotensin system and progression of diabetic nephropathy.
    Jacobsen P; Tarnow L; Carstensen B; Hovind P; Poirier O; Parving HH
    J Am Soc Nephrol; 2003 Nov; 14(11):2843-50. PubMed ID: 14569094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic association analyses of non-synonymous single nucleotide polymorphisms in diabetic nephropathy.
    Savage DA; Patterson CC; Deloukas P; Whittaker P; McKnight AJ; Morrison J; Boulton AJ; Demaine AG; Marshall SM; Millward BA; Thomas SM; Viberti GC; Walker JD; Sadlier D; Maxwell AP; Bain SC
    Diabetologia; 2008 Nov; 51(11):1998-2002. PubMed ID: 18773191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for different susceptibility genes for proteinuria and ESRD in type 2 diabetes.
    Placha G; Canani LH; Warram JH; Krolewski AS
    Adv Chronic Kidney Dis; 2005 Apr; 12(2):155-69. PubMed ID: 15822051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of MCF2L2, ADIPOQ and SOX2 genetic polymorphisms on the development of nephropathy in type 1 Diabetes Mellitus.
    Zhang D; Efendic S; Brismar K; Gu HF
    BMC Med Genet; 2010 Jul; 11():116. PubMed ID: 20667095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A family-based strategy to identify genes for diabetic nephropathy.
    Covic AM; Iyengar SK; Olson JM; Sehgal AR; Constantiner M; Jedrey C; Kara M; Sabbagh E; Sedor JR; Schelling JR
    Am J Kidney Dis; 2001 Mar; 37(3):638-47. PubMed ID: 11228193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of nitric oxide synthase Glu298Asp polymorphism on the development of end-stage renal disease in type 2 diabetic Egyptian patients.
    El-Din Bessa SS; Hamdy SM
    Ren Fail; 2011; 33(9):878-84. PubMed ID: 21854353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SLC12A3 (solute carrier family 12 member [sodium/chloride] 3) polymorphisms are associated with end-stage renal disease in diabetic nephropathy.
    Kim JH; Shin HD; Park BL; Moon MK; Cho YM; Hwang YH; Oh KW; Kim SY; Lee HK; Ahn C; Park KS
    Diabetes; 2006 Mar; 55(3):843-8. PubMed ID: 16505253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.